{"id":7839,"date":"2024-12-04T00:21:33","date_gmt":"2024-12-04T00:21:33","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=7839"},"modified":"2024-12-04T00:21:33","modified_gmt":"2024-12-04T00:21:33","slug":"avanco-pesquisa-clinica-brasil-anvisa","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/","title":{"rendered":"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil: Nova Regulamenta\u00e7\u00e3o da ANVISA"},"content":{"rendered":"<\/p>\n<p style=\"text-align: center;\">A atualiza\u00e7\u00e3o do marco regulat\u00f3rio da ANVISA para pesquisa cl\u00ednica representa uma oportunidade estrat\u00e9gica para empresas que desejam impulsionar o desenvolvimento de medicamentos no Brasil. A redu\u00e7\u00e3o de burocracias e a possibilidade de antecipar a importa\u00e7\u00e3o de medicamentos para pesquisa s\u00e3o avan\u00e7os que n\u00e3o apenas aceleram os estudos, mas tamb\u00e9m trazem previsibilidade e efici\u00eancia para patrocinadores e centros de pesquisa.<\/p>\n<p style=\"text-align: center;\">Na ELS, estamos preparados para ajudar nossos clientes a aproveitar plenamente essas mudan\u00e7as. Nosso servi\u00e7o ELSApdi \u00e9 projetado para facilitar desde a submiss\u00e3o de dados cont\u00ednuos \u00e0 ANVISA at\u00e9 a gest\u00e3o dos processos de importa\u00e7\u00e3o e monitoramento de estudos cl\u00ednicos, garantindo agilidade e conformidade com os novos padr\u00f5es regulat\u00f3rios.<\/p>\n<p style=\"text-align: center;\">Com defini\u00e7\u00f5es mais claras sobre categorias de risco e fases de estudos, a moderniza\u00e7\u00e3o da ANVISA refor\u00e7a a competitividade do Brasil no cen\u00e1rio global. Isso cria um ambiente favor\u00e1vel para integrar a realiza\u00e7\u00e3o de pesquisas cl\u00ednicas com a obten\u00e7\u00e3o de certifica\u00e7\u00f5es internacionais, como a EU GMP, aumentando a relev\u00e2ncia dos produtos brasileiros em mercados externos. Na ELS, vemos essa evolu\u00e7\u00e3o como uma oportunidade para consolidar parcerias estrat\u00e9gicas e oferecer solu\u00e7\u00f5es que agreguem valor em todas as etapas do desenvolvimento cl\u00ednico e regulat\u00f3rio.<\/p>\n<p style=\"text-align: center;\"><span data-olk-copy-source=\"MessageBody\">Se precisar de mais informa\u00e7\u00f5es sobre quest\u00f5es regulat\u00f3rias, a ELS pode certamente ajudar.<\/span><\/p>\n<p style=\"text-align: center;\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Por favor entre em contato com o seu <a href=\"https:\/\/els-solutions.com\/onde-estamos\/\" target=\"_blank\" rel=\"noopener\">consultor local da ELS<\/a> <\/span><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">ou atrav\u00e9s do email: <strong>info@elssolutions.pt<\/strong><\/span><\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil, com o objetivo de modernizar e agilizar os processos de desenvolvimento de medicamentos no pa\u00eds. <\/p>\n","protected":false},"author":9,"featured_media":7841,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[84,67,68,53,65,60,69],"tags":[86,70,64,85],"class_list":["post-7839","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-anvisa","category-els","category-els-group","category-geral","category-medicamentos","category-noticias","category-questoes-regulatorias","tag-anvisa","tag-medicamentos","tag-noticias","tag-pesquisa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil<\/title>\n<meta name=\"description\" content=\"A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa\" \/>\n<meta property=\"og:description\" content=\"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa para garantir o abastecimento de produtos cr\u00edticos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-04T00:21:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil: Nova Regulamenta\u00e7\u00e3o da ANVISA\",\"datePublished\":\"2024-12-04T00:21:33+00:00\",\"dateModified\":\"2024-12-04T00:21:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\"},\"wordCount\":1213,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png\",\"keywords\":[\"ANVISA\",\"medicamentos\",\"Not\u00edcias\",\"pesquisa\"],\"articleSection\":[\"ANVISA`\",\"ELS\",\"ELS Group\",\"Geral\",\"Medicamentos\",\"Not\u00edcias\",\"Quest\u00f5es regulat\u00f3rias\"],\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\",\"name\":\"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png\",\"datePublished\":\"2024-12-04T00:21:33+00:00\",\"dateModified\":\"2024-12-04T00:21:33+00:00\",\"description\":\"A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png\",\"width\":1200,\"height\":600,\"caption\":\"A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil, com o objetivo de modernizar e agilizar os processos de desenvolvimento de medicamentos no pa\u00eds. Esta atualiza\u00e7\u00e3o visa tornar o Brasil um ambiente ainda mais atrativo para investimentos em pesquisa cl\u00ednica e fortalecer o ecossistema de inova\u00e7\u00e3o em sa\u00fade.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil: Nova Regulamenta\u00e7\u00e3o da ANVISA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil","description":"A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/","og_locale":"pt_PT","og_type":"article","og_title":"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa","og_description":"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa para garantir o abastecimento de produtos cr\u00edticos.","og_url":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-12-04T00:21:33+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Marketing ELS","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil: Nova Regulamenta\u00e7\u00e3o da ANVISA","datePublished":"2024-12-04T00:21:33+00:00","dateModified":"2024-12-04T00:21:33+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/"},"wordCount":1213,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png","keywords":["ANVISA","medicamentos","Not\u00edcias","pesquisa"],"articleSection":["ANVISA`","ELS","ELS Group","Geral","Medicamentos","Not\u00edcias","Quest\u00f5es regulat\u00f3rias"],"inLanguage":"pt-PT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/","url":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/","name":"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png","datePublished":"2024-12-04T00:21:33+00:00","dateModified":"2024-12-04T00:21:33+00:00","description":"A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/12\/Anvisa-Pesquisa-clinica.png","width":1200,"height":600,"caption":"A ANVISA acaba de aprovar um novo marco regulat\u00f3rio para a pesquisa cl\u00ednica no Brasil, com o objetivo de modernizar e agilizar os processos de desenvolvimento de medicamentos no pa\u00eds. Esta atualiza\u00e7\u00e3o visa tornar o Brasil um ambiente ainda mais atrativo para investimentos em pesquisa cl\u00ednica e fortalecer o ecossistema de inova\u00e7\u00e3o em sa\u00fade."},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/pt-pt\/avanco-pesquisa-clinica-brasil-anvisa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"Avan\u00e7o na Pesquisa Cl\u00ednica no Brasil: Nova Regulamenta\u00e7\u00e3o da ANVISA"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/pt-pt\/#website","url":"https:\/\/els-solutions.com\/pt-pt\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/pt-pt\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=7839"}],"version-history":[{"count":1,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7839\/revisions"}],"predecessor-version":[{"id":7844,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7839\/revisions\/7844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media\/7841"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=7839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/categories?post=7839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=7839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}